Roth Capital Starts Apricus Biosciences (APRI) at Buy

June 6, 2012 12:42 PM EDT Send to a Friend
Get Alerts APRI Hot Sheet
Price: $0.95 -5%

Rating Summary:
    5 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 28 | New: 51
Trade APRI Now!
Join SI Premium – FREE
Roth Capital initiates coverage on Apricus Biosciences (NASDAQ: APRI) with a Buy.

For an analyst ratings summary and ratings history on Apricus Biosciences click here. For more ratings news on Apricus Biosciences click here.

Shares of Apricus Biosciences closed at $2.49 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment